Prescription drug · BLA
Awiqli (Insulin icodec-abae) NDC 0169-3105
Insulin icodec 700 U/mL · Injection, Solution · Subcutaneous · Novo Nordisk Pharmaceutical Industries, LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0169-3105-11 | 00169310511 | 1 SYRINGE in 1 CARTON (0169-3105-11) / 1.5 mL in 1 SYRINGE (0169-3105-01)Marketed from Aug 3, 2026 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Awiqli
- Generic name (nonproprietary)
- insulin icodec-abae
- Active ingredients
- Insulin icodec — 700 U/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761326
- Marketing start
- Listing expires
- Identifiers
- Product ID 0169-3105_8b15c5f6-3d6e-4e07-8118-7672c063baaaSPL ID 8b15c5f6-3d6e-4e07-8118-7672c063baaa
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400169310511followed by a unit qualifier and the quantityPackage 00169-3105-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0169-3105
- What is NDC 0169-3105?
- 0169-3105 is the product NDC for Awiqli (insulin icodec-abae), Insulin icodec 700 U/mL injection, solution, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Awiqli (Insulin icodec-abae).
- What is the active ingredient?
- Insulin icodec.
- Who is the labeler?
- Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Awiqli?
- 1 other product NDC are listed under this name. See all Awiqli NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Awiqli products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3170 | 00169-3170-97 |
Other NDCs under BLA 761326
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3170 |